nodes	percent_of_prediction	percent_of_DWPC	metapath
Colistimethate—Nephrotoxicity—Cisplatin—esophageal cancer	0.0495	0.0495	CcSEcCtD
Colistimethate—Slurred speech—Cisplatin—esophageal cancer	0.0352	0.0352	CcSEcCtD
Colistimethate—Lower respiratory tract infection—Capecitabine—esophageal cancer	0.034	0.034	CcSEcCtD
Colistimethate—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.0325	0.0325	CcSEcCtD
Colistimethate—Drug hypersensitivity—Capecitabine—esophageal cancer	0.0288	0.0288	CcSEcCtD
Colistimethate—Rales—Capecitabine—esophageal cancer	0.0283	0.0283	CcSEcCtD
Colistimethate—Nephropathy toxic—Cisplatin—esophageal cancer	0.0274	0.0274	CcSEcCtD
Colistimethate—Balance disorder—Capecitabine—esophageal cancer	0.0212	0.0212	CcSEcCtD
Colistimethate—Rales—Methotrexate—esophageal cancer	0.0211	0.0211	CcSEcCtD
Colistimethate—Respiratory distress—Capecitabine—esophageal cancer	0.0183	0.0183	CcSEcCtD
Colistimethate—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.0172	0.0172	CcSEcCtD
Colistimethate—Laryngeal pain—Capecitabine—esophageal cancer	0.017	0.017	CcSEcCtD
Colistimethate—Dysarthria—Cisplatin—esophageal cancer	0.0167	0.0167	CcSEcCtD
Colistimethate—Throat sore—Capecitabine—esophageal cancer	0.0161	0.0161	CcSEcCtD
Colistimethate—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.016	0.016	CcSEcCtD
Colistimethate—Haemoptysis—Capecitabine—esophageal cancer	0.0157	0.0157	CcSEcCtD
Colistimethate—Wheezing—Cisplatin—esophageal cancer	0.0153	0.0153	CcSEcCtD
Colistimethate—Body temperature increased—Carboplatin—esophageal cancer	0.0151	0.0151	CcSEcCtD
Colistimethate—Dysphonia—Capecitabine—esophageal cancer	0.0141	0.0141	CcSEcCtD
Colistimethate—Proteinuria—Capecitabine—esophageal cancer	0.0132	0.0132	CcSEcCtD
Colistimethate—Chest discomfort—Capecitabine—esophageal cancer	0.0131	0.0131	CcSEcCtD
Colistimethate—Protein urine present—Capecitabine—esophageal cancer	0.013	0.013	CcSEcCtD
Colistimethate—Oropharyngeal pain—Capecitabine—esophageal cancer	0.0128	0.0128	CcSEcCtD
Colistimethate—Dysarthria—Capecitabine—esophageal cancer	0.0123	0.0123	CcSEcCtD
Colistimethate—Candida infection—Capecitabine—esophageal cancer	0.0111	0.0111	CcSEcCtD
Colistimethate—Blood creatinine increased—Cisplatin—esophageal cancer	0.0107	0.0107	CcSEcCtD
Colistimethate—Apnoea—Methotrexate—esophageal cancer	0.0102	0.0102	CcSEcCtD
Colistimethate—Proteinuria—Methotrexate—esophageal cancer	0.00984	0.00984	CcSEcCtD
Colistimethate—Protein urine present—Methotrexate—esophageal cancer	0.0097	0.0097	CcSEcCtD
Colistimethate—Abdominal discomfort—Cisplatin—esophageal cancer	0.00947	0.00947	CcSEcCtD
Colistimethate—Oliguria—Methotrexate—esophageal cancer	0.00938	0.00938	CcSEcCtD
Colistimethate—Dysarthria—Methotrexate—esophageal cancer	0.00914	0.00914	CcSEcCtD
Colistimethate—Thirst—Capecitabine—esophageal cancer	0.00886	0.00886	CcSEcCtD
Colistimethate—Blood creatinine increased—Capecitabine—esophageal cancer	0.0079	0.0079	CcSEcCtD
Colistimethate—Urinary tract disorder—Cisplatin—esophageal cancer	0.00781	0.00781	CcSEcCtD
Colistimethate—Connective tissue disorder—Cisplatin—esophageal cancer	0.00777	0.00777	CcSEcCtD
Colistimethate—Urethral disorder—Cisplatin—esophageal cancer	0.00775	0.00775	CcSEcCtD
Colistimethate—Tinnitus—Cisplatin—esophageal cancer	0.00737	0.00737	CcSEcCtD
Colistimethate—Asthma—Capecitabine—esophageal cancer	0.00728	0.00728	CcSEcCtD
Colistimethate—Bronchospasm—Capecitabine—esophageal cancer	0.00716	0.00716	CcSEcCtD
Colistimethate—Immune system disorder—Cisplatin—esophageal cancer	0.00714	0.00714	CcSEcCtD
Colistimethate—Mediastinal disorder—Cisplatin—esophageal cancer	0.00713	0.00713	CcSEcCtD
Colistimethate—Abdominal discomfort—Capecitabine—esophageal cancer	0.00698	0.00698	CcSEcCtD
Colistimethate—Malnutrition—Cisplatin—esophageal cancer	0.00689	0.00689	CcSEcCtD
Colistimethate—Flatulence—Cisplatin—esophageal cancer	0.00678	0.00678	CcSEcCtD
Colistimethate—Epistaxis—Capecitabine—esophageal cancer	0.00613	0.00613	CcSEcCtD
Colistimethate—Convulsion—Cisplatin—esophageal cancer	0.00597	0.00597	CcSEcCtD
Colistimethate—Anxiety—Cisplatin—esophageal cancer	0.00584	0.00584	CcSEcCtD
Colistimethate—Urinary tract disorder—Capecitabine—esophageal cancer	0.00576	0.00576	CcSEcCtD
Colistimethate—Connective tissue disorder—Capecitabine—esophageal cancer	0.00573	0.00573	CcSEcCtD
Colistimethate—Urethral disorder—Capecitabine—esophageal cancer	0.00572	0.00572	CcSEcCtD
Colistimethate—Nervous system disorder—Cisplatin—esophageal cancer	0.00551	0.00551	CcSEcCtD
Colistimethate—Tinnitus—Capecitabine—esophageal cancer	0.00544	0.00544	CcSEcCtD
Colistimethate—Asthma—Methotrexate—esophageal cancer	0.00542	0.00542	CcSEcCtD
Colistimethate—Immune system disorder—Capecitabine—esophageal cancer	0.00527	0.00527	CcSEcCtD
Colistimethate—Mediastinal disorder—Capecitabine—esophageal cancer	0.00525	0.00525	CcSEcCtD
Colistimethate—Abdominal discomfort—Methotrexate—esophageal cancer	0.0052	0.0052	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00512	0.00512	CcSEcCtD
Colistimethate—Mental disorder—Capecitabine—esophageal cancer	0.00511	0.00511	CcSEcCtD
Colistimethate—Malnutrition—Capecitabine—esophageal cancer	0.00508	0.00508	CcSEcCtD
Colistimethate—Paraesthesia—Cisplatin—esophageal cancer	0.00505	0.00505	CcSEcCtD
Colistimethate—Dyspnoea—Cisplatin—esophageal cancer	0.00501	0.00501	CcSEcCtD
Colistimethate—Flatulence—Capecitabine—esophageal cancer	0.005	0.005	CcSEcCtD
Colistimethate—Dysgeusia—Capecitabine—esophageal cancer	0.00497	0.00497	CcSEcCtD
Colistimethate—Decreased appetite—Cisplatin—esophageal cancer	0.00488	0.00488	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00485	0.00485	CcSEcCtD
Colistimethate—Epistaxis—Methotrexate—esophageal cancer	0.00456	0.00456	CcSEcCtD
Colistimethate—Vertigo—Capecitabine—esophageal cancer	0.00456	0.00456	CcSEcCtD
Colistimethate—Body temperature increased—Cisplatin—esophageal cancer	0.00444	0.00444	CcSEcCtD
Colistimethate—Cough—Capecitabine—esophageal cancer	0.00443	0.00443	CcSEcCtD
Colistimethate—Arthralgia—Capecitabine—esophageal cancer	0.00432	0.00432	CcSEcCtD
Colistimethate—Chest pain—Capecitabine—esophageal cancer	0.00432	0.00432	CcSEcCtD
Colistimethate—Anxiety—Capecitabine—esophageal cancer	0.00431	0.00431	CcSEcCtD
Colistimethate—Urinary tract disorder—Methotrexate—esophageal cancer	0.00429	0.00429	CcSEcCtD
Colistimethate—Urethral disorder—Methotrexate—esophageal cancer	0.00425	0.00425	CcSEcCtD
Colistimethate—Hypersensitivity—Cisplatin—esophageal cancer	0.00414	0.00414	CcSEcCtD
Colistimethate—Nervous system disorder—Capecitabine—esophageal cancer	0.00406	0.00406	CcSEcCtD
Colistimethate—Tinnitus—Methotrexate—esophageal cancer	0.00405	0.00405	CcSEcCtD
Colistimethate—Asthenia—Cisplatin—esophageal cancer	0.00403	0.00403	CcSEcCtD
Colistimethate—Immune system disorder—Methotrexate—esophageal cancer	0.00392	0.00392	CcSEcCtD
Colistimethate—Mediastinal disorder—Methotrexate—esophageal cancer	0.00391	0.00391	CcSEcCtD
Colistimethate—Diarrhoea—Cisplatin—esophageal cancer	0.00384	0.00384	CcSEcCtD
Colistimethate—Mental disorder—Methotrexate—esophageal cancer	0.0038	0.0038	CcSEcCtD
Colistimethate—Malnutrition—Methotrexate—esophageal cancer	0.00378	0.00378	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00377	0.00377	CcSEcCtD
Colistimethate—Paraesthesia—Capecitabine—esophageal cancer	0.00372	0.00372	CcSEcCtD
Colistimethate—Dysgeusia—Methotrexate—esophageal cancer	0.0037	0.0037	CcSEcCtD
Colistimethate—Dyspnoea—Capecitabine—esophageal cancer	0.00369	0.00369	CcSEcCtD
Colistimethate—Decreased appetite—Capecitabine—esophageal cancer	0.0036	0.0036	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00358	0.00358	CcSEcCtD
Colistimethate—Vomiting—Cisplatin—esophageal cancer	0.00357	0.00357	CcSEcCtD
Colistimethate—Fatigue—Capecitabine—esophageal cancer	0.00357	0.00357	CcSEcCtD
Colistimethate—Rash—Cisplatin—esophageal cancer	0.00354	0.00354	CcSEcCtD
Colistimethate—Dermatitis—Cisplatin—esophageal cancer	0.00354	0.00354	CcSEcCtD
Colistimethate—Vertigo—Methotrexate—esophageal cancer	0.00339	0.00339	CcSEcCtD
Colistimethate—Nausea—Cisplatin—esophageal cancer	0.00334	0.00334	CcSEcCtD
Colistimethate—Cough—Methotrexate—esophageal cancer	0.0033	0.0033	CcSEcCtD
Colistimethate—Urticaria—Capecitabine—esophageal cancer	0.00329	0.00329	CcSEcCtD
Colistimethate—Body temperature increased—Capecitabine—esophageal cancer	0.00327	0.00327	CcSEcCtD
Colistimethate—Convulsion—Methotrexate—esophageal cancer	0.00327	0.00327	CcSEcCtD
Colistimethate—Chest pain—Methotrexate—esophageal cancer	0.00322	0.00322	CcSEcCtD
Colistimethate—Arthralgia—Methotrexate—esophageal cancer	0.00322	0.00322	CcSEcCtD
Colistimethate—Hypersensitivity—Capecitabine—esophageal cancer	0.00305	0.00305	CcSEcCtD
Colistimethate—Nervous system disorder—Methotrexate—esophageal cancer	0.00302	0.00302	CcSEcCtD
Colistimethate—Asthenia—Capecitabine—esophageal cancer	0.00297	0.00297	CcSEcCtD
Colistimethate—Diarrhoea—Capecitabine—esophageal cancer	0.00283	0.00283	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00281	0.00281	CcSEcCtD
Colistimethate—Paraesthesia—Methotrexate—esophageal cancer	0.00277	0.00277	CcSEcCtD
Colistimethate—Dyspnoea—Methotrexate—esophageal cancer	0.00275	0.00275	CcSEcCtD
Colistimethate—Somnolence—Methotrexate—esophageal cancer	0.00274	0.00274	CcSEcCtD
Colistimethate—Dizziness—Capecitabine—esophageal cancer	0.00274	0.00274	CcSEcCtD
Colistimethate—Decreased appetite—Methotrexate—esophageal cancer	0.00268	0.00268	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00266	0.00266	CcSEcCtD
Colistimethate—Fatigue—Methotrexate—esophageal cancer	0.00266	0.00266	CcSEcCtD
Colistimethate—Vomiting—Capecitabine—esophageal cancer	0.00263	0.00263	CcSEcCtD
Colistimethate—Rash—Capecitabine—esophageal cancer	0.00261	0.00261	CcSEcCtD
Colistimethate—Dermatitis—Capecitabine—esophageal cancer	0.00261	0.00261	CcSEcCtD
Colistimethate—Headache—Capecitabine—esophageal cancer	0.00259	0.00259	CcSEcCtD
Colistimethate—Nausea—Capecitabine—esophageal cancer	0.00246	0.00246	CcSEcCtD
Colistimethate—Urticaria—Methotrexate—esophageal cancer	0.00245	0.00245	CcSEcCtD
Colistimethate—Body temperature increased—Methotrexate—esophageal cancer	0.00244	0.00244	CcSEcCtD
Colistimethate—Hypersensitivity—Methotrexate—esophageal cancer	0.00227	0.00227	CcSEcCtD
Colistimethate—Asthenia—Methotrexate—esophageal cancer	0.00221	0.00221	CcSEcCtD
Colistimethate—Diarrhoea—Methotrexate—esophageal cancer	0.00211	0.00211	CcSEcCtD
Colistimethate—Dizziness—Methotrexate—esophageal cancer	0.00204	0.00204	CcSEcCtD
Colistimethate—Vomiting—Methotrexate—esophageal cancer	0.00196	0.00196	CcSEcCtD
Colistimethate—Rash—Methotrexate—esophageal cancer	0.00194	0.00194	CcSEcCtD
Colistimethate—Dermatitis—Methotrexate—esophageal cancer	0.00194	0.00194	CcSEcCtD
Colistimethate—Headache—Methotrexate—esophageal cancer	0.00193	0.00193	CcSEcCtD
Colistimethate—Nausea—Methotrexate—esophageal cancer	0.00183	0.00183	CcSEcCtD
